iRhythm Technologies (IRTC) Tops Q2 EPS by 63c; Offers Guidance

iRhythm Technologies (NASDAQ: IRTC) reported Q2 EPS of $0.58, $0.63 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $224.17 million versus the consensus estimate of $219.29 million.

FY2026 Outlook-

Revenue between $880 million to $890 million versus the consensus $881.2 million.

For earnings history and earnings-related data on iRhythm Technologies (IRTC) click here.

You May Also Be Interested In

• Veritone (VERI) Misses Q2 EPS by 13c ; Offers Guidance
• StoneCo (STNE) Reports In-Line Q2 EPS
• Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c